Erasca, Inc. Common Stock (ERAS) Stock
NASDAQ · ERAS
14.77
Fundamentals
Market cap
$5.17B
Price / Earnings ratio
-18.7x
Price / Sales ratio
N/A
Price / Book ratio
14.8x
Return on assets
-0.6%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Erasca, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees103
CEODr. Jonathan E. Lim M.D.
IPO DateJul 14, 2021
HeadquartersSan Diego, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jonathan E. Lim M.D. | Co-Founder, Chairman & CEO | 1972 |
| Dr. David M. Chacko M.D. | CFO & Chief Business Officer | 1983 |
| Dr. Michael D. Varney Ph.D. | Chairman of Research & Development, Scientific Advisory Board Member and Director | 1958 |
| Dr. Shannon R. Morris M.D., Ph.D. | Chief Medical Officer | 1970 |
| Dr. Nik Chetwyn Ph.D. | Chief Operating Officer | — |
| Ms. Alison Tjosvold Milhous | Senior Vice President of Accounting | 1979 |
| Dr. Robert Shoemaker Ph.D. | Chief Scientific Officer | 1981 |
| Mr. Ebun S. Garner Esq., J.D. | Chief Legal Officer & Corporate Secretary | 1972 |
| Dr. Lisa Tesvich-Bonora Ph.D. | Chief People Officer | — |
| Mr. Brian L. Baker CPA, M.S. | Senior Vice President of Finance | 1967 |
Fundamentals
Valuation
Market cap$5.17B
Price-to-sales ratioN/A
Price-to-book value14.83
Price-earnings ratio-18.70
Return on Equity-77.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.95
Income Statement
Average volume4,204,594
EBITDA$-274.01M
1 year high (52w)$24.28
1 year low (52w)$1.67
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



